| A Study to Investigate LYL797 in Adults With Solid Tumors (NCT05274451) | Lyell Immunopharma, Inc. | 2022-03-29 |
| A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) (NCT05001282) | Elucida Oncology | 2021-09-13 |
| Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors (NCT06785077) | European Institute of Oncology | 2020-10-02 |
| Cytoreductive Surgery and HIPEC in First or Secondary Platinum-resistant Recurrent Ovarian Epithelial Cancer (NCT03220932) | Hospices Civils de Lyon | 2019-11-30 |
| A Clinical Study of Gimatecan in Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer (NCT04029909) | Lee's Pharmaceutical Limited | 2019-07-11 |
| Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers. (NCT03349463) | Bital Savir-Baruch | 2018-11-14 |
| Early Detection of High Grade Ovarian Cancer Using Uterine Lavage EHUD Study and Duplex Sequencing (NCT04823871) | Paul Speiser, Prof.MD, | 2018-11-01 |
| Preoperative Ascites Drainage Versus Standard Care for Patients With Advanced Ovarian Cancer (NCT02742428) | Gdynia Oncology Center | 2018-01-01 |
| Safety and Efficacy Study of Daily SPL-108 Injections In Conjunction With Paclitaxel in Women With Ovarian Cancer (NCT03078400) | Splash Pharmaceuticals, Inc. | 2017-03-10 |
| Circulating Tumor DNA Guiding (Olaparib) Lynparza® Treatment in Ovarian Cancer (NCT02822157) | Universitaire Ziekenhuizen KU Leuven | 2016-08-01 |
| RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT) (NCT02489903) | EpicentRx, Inc. | 2015-06-01 |
| p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer (NCT02435186) | Shenzhen SiBiono GeneTech Co.,Ltd | 2015-06-01 |
| Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer (NCT02096783) | University of Wisconsin, Madison | 2014-09-01 |
| Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma - Study of Sensitivity and Specificity (NCT02518256) | Medical University of Vienna | 2014-05-01 |
| Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian Carcinoma (NCT02107950) | SOTIO a.s. | 2013-11-01 |
| Lavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial Carcinoma (NCT02039388) | Medical University of Vienna | 2013-11-01 |
| Phase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian Carcinoma (NCT02107937) | SOTIO a.s. | 2013-11-01 |
| Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer (NCT01631552) | Gilead Sciences | 2012-12-17 |
| Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia (NCT01484015) | Wake Forest University Health Sciences | 2011-02-01 |
| Safety of Active Immunotherapy in Subjects With Ovarian Cancer (NCT01456065) | Life Research Technologies GmbH | 2010-09-01 |
| Pelvic Floor Muscle Training in Treating Urinary Incontinence in Gynecologic Cancer Survivors (NCT01806350) | New Mexico Cancer Research Alliance | 2009-11-01 |